Annual Drug Patent Expirations for LESCOL+XL
Lescol Xl is a drug marketed by Novartis and is included in one NDA. It is available from two suppliers. There is one patent protecting this drug and one Paragraph IV challenge.
Drug patent litigation for LESCOL XL.
The generic ingredient in LESCOL XL is fluvastatin sodium. Two suppliers are listed for this compound. Additional details are available on the fluvastatin sodium profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
